Jacques BPharm - Tabula Rasa RD Pharmacotherapy
TRHCDelisted Stock | USD 8.16 0.62 7.06% |
Insider
Jacques BPharm is RD Pharmacotherapy of Tabula Rasa HealthCare
Age | 63 |
Phone | 866 648 2767 |
Web | https://www.tabularasahealthcare.com |
Tabula Rasa Management Efficiency
The company has return on total asset (ROA) of (0.0598) % which means that it has lost $0.0598 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.552) %, meaning that it created substantial loss on money invested by shareholders. Tabula Rasa's management efficiency ratios could be used to measure how well Tabula Rasa manages its routine affairs as well as how well it operates its assets and liabilities.Tabula Rasa HealthCare currently holds 336.13 M in liabilities. Tabula Rasa HealthCare has a current ratio of 1.7, which is within standard range for the sector. Note, when we think about Tabula Rasa's use of debt, we should always consider it together with its cash and equity.
Similar Executives
Showing other executives | INSIDER Age | ||
Jon Maack | Definitive Healthcare Corp | N/A | |
Helen Hrdy | National Research Corp | 59 | |
Ben Stilwill | Streamline Health Solutions | N/A | |
Jon Boumstein | National Research Corp | N/A | |
Mark Grove | Forian Inc | N/A | |
Donald Vick | Streamline Health Solutions | 60 | |
Jacob Goldberger | Streamline Health Solutions | N/A | |
Jona Raasch | National Research Corp | 65 | |
Jawad Shaikh | Streamline Health Solutions | N/A | |
Daniel Barton | Forian Inc | 59 | |
Michael Vesey | Forian Inc | 62 | |
Kate Jensen | Definitive Healthcare Corp | 38 | |
Amy Sebero | Streamline Health Solutions | N/A | |
Wendy Lucio | Streamline Health Solutions | N/A | |
Justin Steinman | Definitive Healthcare Corp | N/A | |
Max Wygod | Forian Inc | 36 | |
David Kronfeld | Definitive Healthcare Corp | N/A | |
Andrew Douglas | Forian Inc | N/A | |
Scott Oberlink | Definitive Healthcare Corp | N/A | |
David Terrell | Forian Inc | N/A | |
MB CCS | Streamline Health Solutions | N/A |
Management Performance
Return On Equity | -5.55 | |||
Return On Asset | -0.0598 |
Tabula Rasa HealthCare Leadership Team
Elected by the shareholders, the Tabula Rasa's board of directors comprises two types of representatives: Tabula Rasa inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tabula. The board's role is to monitor Tabula Rasa's management team and ensure that shareholders' interests are well served. Tabula Rasa's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tabula Rasa's outside directors are responsible for providing unbiased perspectives on the board's policies.
Brian Adams, Pres CEO | ||
Michael Greenhalgh, Chief Officer | ||
Bob MS, Chief Officer | ||
CPA CFA, Chief Officer | ||
Jacques BPharm, RD Pharmacotherapy | ||
Kathleen MBA, Chief Officer | ||
Andrea MS, Co Officer | ||
Phillip MS, Chief Officer | ||
JD DMIN, G Counsel |
Tabula Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tabula Rasa a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -5.55 | |||
Return On Asset | -0.0598 | |||
Profit Margin | (0.28) % | |||
Operating Margin | (0.06) % | |||
Current Valuation | 548.09 M | |||
Shares Outstanding | 27.05 M | |||
Shares Owned By Insiders | 12.09 % | |||
Shares Owned By Institutions | 70.69 % | |||
Number Of Shares Shorted | 732.92 K | |||
Price To Earning | 67.61 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Tabula Stock
If you are still planning to invest in Tabula Rasa HealthCare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tabula Rasa's history and understand the potential risks before investing.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |